These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1532940)

  • 41. A comparison of the effects of prednisolone and mianserin on ventilatory, exercise and psychometric parameters in patients with chronic obstructive pulmonary disease.
    Grove A; Lipworth BJ; Ingram CG; Clark RA; Dhillon DP
    Eur J Clin Pharmacol; 1995; 48(1):13-8. PubMed ID: 7621841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Magnesium for acute exacerbation of chronic obstructive pulmonary disease: A systematic review of randomised trials.
    Shivanthan MC; Rajapakse S
    Ann Thorac Med; 2014 Apr; 9(2):77-80. PubMed ID: 24791169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment and provision of home nebulizers for chronic obstructive pulmonary disease (COPD) in the Yorkshire region of the U.K.
    Hosker HS; Teale C; Greenstone MA; Muers MF
    Respir Med; 1995 Jan; 89(1):47-52. PubMed ID: 7708980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of the 12 minute walking test in assessing the effect of oral steroid therapy in patients with chronic airways obstruction.
    O'Reilly JF; Shaylor JM; Fromings KM; Harrison BD
    Br J Dis Chest; 1982 Oct; 76(4):374-82. PubMed ID: 6758833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectivness of Nebulized Budesonide for COPD Exacerbation Management in Emergency Department; a Randomized Clinical Trial.
    Aghili M; Vahidi E; Mohammadrezaei N; Mirrajei T; Abedini A
    Arch Acad Emerg Med; 2020; 8(1):e85. PubMed ID: 33244520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Starting home nebulizer therapy: patients' expectations and subsequent outcome at 2 months.
    Simpson AJ; Tweeddale PM; Crompton GK
    Respir Med; 1998 Aug; 92(8):1000-2. PubMed ID: 9893765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Audit of a complete home nebulizer service provided by a respiratory nurse specialist.
    Hall IP; Callow IM; Evans SA; Johnston ID
    Respir Med; 1994 Jul; 88(6):429-33. PubMed ID: 7938793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical usefulness of n-of-1 randomized controlled trials in patients with nonreversible chronic airflow limitation.
    Patel A; Jaeschke R; Guyatt GH; Keller JL; Newhouse MT
    Am Rev Respir Dis; 1991 Oct; 144(4):962-4. PubMed ID: 1928975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Steroid trials in the assessment of reversibility of air flow limitation: a survey of current clinical practice of chest physicians.
    Wiggins J; Feher MD; Lant AF; Collins JV
    Respir Med; 1991 Jul; 85(4):295-9. PubMed ID: 1947366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy of nebulized furosemide and salbutamol compared with salbutamol alone in reactive airway disease: a double blind randomized, clinical trial.
    Masoumi K; Forouzan A; Haddadzadeh Shoushtari M; Porozan S; Feli M; Fallah Bagher Sheidaee M; Asgari Darian A
    Emerg Med Int; 2014; 2014():638102. PubMed ID: 24876968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.
    Kässner F; Hodder R; Bateman ED
    Drugs; 2004; 64(15):1671-82. PubMed ID: 15257628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.
    Sestini P; Ram FS
    Cochrane Database Syst Rev; 2000; 2002(2):CD001495. PubMed ID: 10796652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.
    Thorax; 1997 Dec; 52 Suppl 5(Suppl 5):S1-28. PubMed ID: 9474238
    [No Abstract]   [Full Text] [Related]  

  • 54. Nebulisers for chronic obstructive pulmonary disease.
    O'Driscoll BR
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S49-52. PubMed ID: 9155851
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.
    Moayyedi P; Congleton J; Page RL; Pearson SB; Muers MF
    Thorax; 1995 Aug; 50(8):834-7. PubMed ID: 7570433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation.
    Morrison JF; Jones PC; Muers MF
    Eur Respir J; 1992 Apr; 5(4):424-9. PubMed ID: 1532940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversibility tests in chronic obstructive airways disease: their predictive value with reference to benefit from domiciliary nebuliser therapy.
    Teale C; Morrison JF; Jones PC; Muers MF
    Respir Med; 1991 Jul; 85(4):281-4. PubMed ID: 1835110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of domiciliary nebulizers in managing patients with severe COPD.
    Eiser N; Angus K; McHale S
    Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simplifying the assessment of patients with chronic airflow limitation for home nebulizer therapy.
    Goldman JM; Teale C; Muers MF
    Respir Med; 1992 Jan; 86(1):33-8. PubMed ID: 1533047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of the effects of anticholinergic and beta 2-agonist and combination therapy on respiratory impedance in COPD.
    Wesseling G; Mostert R; Wouters EF
    Chest; 1992 Jan; 101(1):166-73. PubMed ID: 1530836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.